East West Bank
EWBC
$126.92
+0.90%
East West Bancorp Inc., operating as East West Bank, is a regional bank holding company that provides a broad range of personal and commercial banking services across the United States and Asia, including deposit products, foreign exchange, treasury management, and wealth management. The company is distinguished by its cross-border franchise, with three operating segments—Consumer and Business Banking, Commercial Banking, and Treasury and Other—and it generates the majority of its revenue from the Commercial Banking segment, positioning it as a niche player in the U.S. regional banking landscape with a unique Asia-Pacific connectivity. The current investor narrative centers on the bank's ability to sustain net interest margin expansion amid a stabilizing rate environment, while also managing credit quality and deposit costs. Recent quarterly results show year-over-year revenue growth of approximately 4% and net income of $357.8 million, which has kept the stock in focus for value-oriented investors seeking exposure to a well-capitalized regional bank with international reach. However, the broader regional banking sector continues to face scrutiny over commercial real estate exposure and regulatory capital requirements, creating a balanced debate around EWBC's risk-reward profile.…
EWBC
East West Bank
$126.92
Investment Opinion: Should I buy EWBC Today?
The synthesized recommendation is Buy, anchored by a consensus analyst rating of Buy (mean 1.56 from 16 analysts) and an average target price of $149.75, which implies 18.0% upside from the current $126.92. The core thesis is that EWBC offers a rare combination of value (forward PE 11.14, PEG 0.83), profitability (ROE 14.89%, net margin 30.86%), and a differentiated cross-border franchise, with limited downside given the conservative balance sheet (debt-to-equity 0.357) and strong free cash flow ($1.553 billion TTM).
The supporting evidence is compelling: revenue grew 3.98% year-over-year in Q1 2026, net margin expanded to 30.86% from 26.04%, and gross margin improved to 63.74% from 56.89%. The dividend yield of 2.15% with a low payout ratio of 25.21% provides income and safety, while the price-to-book of 1.75, though above the industry average of 1.2x–1.5x, is justified by the superior ROE. The implied upside to the average target is 18.0%, and the PEG ratio below 1.0 suggests the stock is undervalued relative to its growth prospects.
The biggest risks that could invalidate this thesis are a continued sequential decline in revenue, a sharp rise in credit costs, and multiple compression if the bank misses earnings expectations. This Buy would downgrade to Hold if revenue growth turns negative or if net interest margin contracts for two consecutive quarters; it would upgrade to Strong Buy if the forward PE falls below 10x without a deterioration in credit quality. Relative to its own history, EWBC is trading at a premium on price-to-book (1.75 vs. historical midpoint around 1.55) but at a discount on earnings (PE 11.73 vs. historical high of 12.86), making the valuation verdict fairly valued to slightly undervalued on an earnings basis.
Sign up to view all
EWBC 12-Month Price Forecast
EWBC presents a favorable risk-reward profile, with a discounted earnings multiple, improving profitability, and a unanimous analyst Buy consensus. The primary concern is the sequential revenue decline, which, if not reversed in Q2 2026, could pressure the stock toward the low end of the base case. The cross-border franchise and conservative balance sheet provide downside protection, but the premium price-to-book of 1.75 leaves little room for execution missteps. I would upgrade to high confidence if Q2 2026 revenue exceeds $1.17 billion and net interest margin expands; I would downgrade to neutral if revenue falls below $1.15 billion or if credit costs rise above 40 basis points.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on East West Bank's 12-month outlook, with a consensus price target around $149.88 and implied upside of +18.1% versus the current price.
Average Target
$149.88
0 analysts
Implied Upside
+18.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$134 - $160
Analyst target range
EWBC is covered by 16 analysts, with a consensus recommendation of "Buy" and a recommendation mean of 1.56 (on a scale where 1 is Strong Buy and 5 is Strong Sell). The average target price is $149.75, which implies an upside of approximately 18.0% from the current price of $126.92. The consensus leans bullish, with a majority of analysts rating the stock as a Buy or Overweight, as evidenced by recent ratings from firms such as Cantor Fitzgerald (Overweight), Barclays (Overweight), Wells Fargo (Overweight), and Citigroup (Buy). The estimated EPS average for the upcoming fiscal year is $12.13, which would represent significant growth from the trailing EPS of $0.085 (likely a data anomaly) and supports the optimistic targets. The target price range spans from a low of $134.00 to a high of $160.00, a spread of $26.00 or 19.4% of the average target. The high target of $160.00 implies a PE of approximately 13.2x on the estimated EPS of $12.13, assuming multiple expansion and successful execution of growth initiatives. The low target of $134.00 suggests a more conservative view, potentially pricing in margin compression or slower loan growth. The wide spread indicates moderate uncertainty among analysts, but the clustering of ratings in the Buy/Overweight category suggests strong conviction in the bank's fundamentals. Recent institutional ratings show a mix of Overweight, Hold, and Buy ratings, with no recent downgrades, indicating stable sentiment. The presence of 16 analysts provides adequate coverage, reducing the risk of inefficient price discovery, though the stock may still be subject to volatility given its mid-cap status and sector-specific risks.
Drowning in data?
Find the real signal!
Bulls vs Bears: EWBC Investment Factors
The bull case rests on EWBC's discounted earnings multiple (forward PE 11.14), strong profitability (ROE 14.89%, net margin 30.86%), and a unanimous analyst Buy consensus with 18% upside to the $149.75 average target. The bear case centers on decelerating revenue growth (Q1 2026 revenue down sequentially from Q3 2025), a premium price-to-book of 1.75 versus peers, and stalling short-term momentum (-2.67% over one month). Currently, the bull evidence is stronger: the valuation is undemanding on earnings, profitability is improving, and analyst sentiment is firmly positive with no recent downgrades. The single most important tension is whether net interest margin can stabilize and re-accelerate after the sequential revenue decline; if Q2 2026 revenue rebounds above $1.17 billion, the bull case likely prevails, but a second consecutive sequential decline would validate the bear thesis and likely trigger multiple compression.
Bullish
- Analyst consensus Buy with 18% upside: 16 analysts cover EWBC with a consensus recommendation of Buy (mean 1.56) and an average target price of $149.75, implying 18.0% upside from the current $126.92. The target range of $134.00–$160.00 shows no analyst expects downside, and recent ratings from Cantor Fitzgerald, Barclays, Wells Fargo, and Citigroup are all Overweight or Buy.
- Undervalued on earnings and PEG: The trailing PE of 11.73 and forward PE of 11.14 are near the low end of the regional bank sector (typically 10x–14x), while the PEG ratio of 0.83 is below 1.0, suggesting the stock is cheap relative to expected earnings growth. The forward PE implies only a modest 5.3% earnings growth expectation, leaving room for positive surprises.
- Margin expansion and profitability: Q1 2026 net margin improved to 30.86% from 26.04% a year earlier, while gross margin rose to 63.74% from 56.89%. ROE of 14.89% and ROA of 1.78% are healthy for a regional bank and support the premium price-to-book multiple of 1.75.
- Strong capital return and liquidity: Free cash flow on a trailing twelve-month basis is $1.553 billion, and the dividend payout ratio is only 25.21% with a 2.15% yield, leaving ample room for continued dividends and buybacks. The debt-to-equity ratio of 0.357 is conservative for a bank.
Bearish
- Revenue growth is decelerating: Q1 2026 revenue of $1.159 billion grew only 3.98% year-over-year and declined sequentially from $1.173 billion in Q4 2025 and $1.255 billion in Q3 2025. The top-line peak in Q3 2025 suggests net interest income pressure from deposit repricing or weaker loan demand.
- Premium valuation versus history and book: The price-to-book ratio of 1.75 is above the industry average of 1.2x–1.5x and above the midpoint of EWBC's historical range (1.13–1.97). The trailing PE of 11.73 is near the upper end of its historical range (5.97–12.86), leaving limited room for multiple expansion and raising the risk of compression if growth disappoints.
- Low interest coverage and cash flow to debt: The interest coverage ratio of 1.19 is thin, and the cash flow to debt ratio of 0.117 indicates that debt service consumes a meaningful portion of cash flow. While typical for banks, these metrics warrant monitoring if credit conditions deteriorate.
- Short-term momentum has stalled: The stock is down 2.67% over the past month and has underperformed the S&P 500 by 1.71 percentage points, with a 3-month change of just +0.09%. The 1-month relative strength of -1.71% and 3-month relative strength of -1.91% show a loss of near-term leadership.
EWBC Technical Analysis
EWBC is in a sustained uptrend over the past year, with a 1-year price change of +15.70%, though it has recently pulled back from its 52-week high of $137.47. The current price of $126.92 sits at approximately 76.6% of the 52-week range (calculated as ($126.92 - $92.67) / ($137.47 - $92.67)), indicating that while the stock is closer to its highs than its lows, it has retreated from peak levels. This positioning suggests a market that has rewarded the stock's fundamental performance but is now consolidating gains, with the potential for either a renewed breakout or a deeper correction depending on upcoming catalysts. The 6-month change of +22.59% underscores the strength of the intermediate-term trend, but the recent 1-month decline of -2.67% signals a loss of short-term momentum. The 3-month change of +0.09% is essentially flat, revealing a deceleration from the robust 6-month performance and a divergence from the 1-year uptrend. This divergence could indicate a temporary pause or a trend reversal, especially as the stock underperformed the S&P 500 by 1.71 percentage points over the past month (relative strength 1-month of -1.71%). The 1-year relative strength of +0.69% shows only marginal outperformance versus the broader market, while the 6-month relative strength of +5.15% highlights that the bulk of the outperformance occurred earlier in the year. With a beta of 0.925, EWBC is slightly less volatile than the market, which may appeal to risk-averse investors but also implies it may lag in strong rallies. Key technical support lies near the 52-week low of $92.67, while resistance is established at the 52-week high of $137.47. A breakout above $137.47 would signal renewed bullish momentum and potentially attract trend-following capital, whereas a breakdown below $92.67 would confirm a bearish reversal and could trigger stop-loss selling. The max drawdown of -15.71% over the period indicates that the stock has experienced moderate peak-to-trough declines, consistent with a beta below 1 and a relatively stable trading history.
Beta
0.93
0.93x market volatility
Max Drawdown
-15.7%
Largest decline past year
52-Week Range
$93-$137
Price range past year
Annual Return
+15.7%
Cumulative gain past year
| Period | EWBC Return | S&P 500 |
|---|---|---|
| 1m | -2.7% | -0.5% |
| 3m | +0.1% | +2.3% |
| 6m | +22.6% | +16.6% |
| 1y | +15.7% | +14.8% |
| ytd | +10.3% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EWBC Fundamental Analysis
EWBC's revenue trajectory shows modest growth, with the most recent quarter (Q1 2026) reporting revenue of $1.159 billion, up 3.98% year-over-year from $1.115 billion in Q1 2025. Sequentially, revenue declined from $1.173 billion in Q4 2025 and $1.255 billion in Q3 2025, indicating some softening in the top line. The revenue mix is diversified across segments, with Commercial Banking contributing $315.6 million, Consumer and Business Banking $309.2 million, and Treasury and Other $148.9 million, but the sequential decline suggests that net interest income may be facing pressure from deposit repricing or lower loan demand. The multi-quarter trend reveals that revenue peaked in Q3 2025 and has since moderated, which could signal a challenging environment for net interest margin expansion. Profitability remains robust, with Q1 2026 net income of $357.8 million and a net margin of 30.86%, up from 26.04% in Q1 2025. The gross margin of 63.74% in Q1 2026 improved from 56.89% a year earlier, and the operating margin of 39.46% reflects strong cost control. The company's return on equity (ROE) of 14.89% and return on assets (ROA) of 1.78% are healthy for a regional bank, though the net income ratio has been volatile, ranging from 26% to 31% over the past five quarters. The improvement in margins is notable, but the sequential decline in revenue could pressure future profitability if not reversed. The balance sheet shows a debt-to-equity ratio of 0.357, which is conservative for a bank, and a current ratio of 0.324, reflecting the typical asset-liability structure of financial institutions. Free cash flow on a trailing twelve-month basis is $1.553 billion, providing ample liquidity to fund operations and return capital to shareholders, with a dividend payout ratio of 25.21% and a dividend yield of 2.15%. The company's price-to-cash-flow ratio of 10.35 and EV/EBITDA of 9.32 suggest reasonable cash flow generation relative to its valuation. However, the interest coverage ratio of 1.19 is low, typical for banks where interest expense is a core operating cost, and the cash flow to debt ratio of 0.117 indicates that debt levels are manageable but warrant monitoring.
Quarterly Revenue
$1.2B
2026-03
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
63.7%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EWBC Overvalued?
Since EWBC reported positive net income of $357.8 million in the most recent quarter, the PE ratio is the appropriate primary valuation metric. The trailing PE ratio is 11.73, while the forward PE is 11.14, implying a slight earnings growth expectation. The small gap between trailing and forward PE suggests that the market is not pricing in aggressive earnings acceleration, which is consistent with the modest revenue growth and stable profitability. The PEG ratio of 0.83, below 1.0, indicates that the stock may be undervalued relative to its expected earnings growth, though the low growth rate tempers this signal. Compared to the regional banking industry, EWBC's PE of 11.73 is in line with or slightly below the sector average, which typically ranges from 10x to 14x. The price-to-book ratio of 1.75 is above the industry average of around 1.2x to 1.5x, suggesting a premium that may be justified by the bank's superior ROE of 14.89% and its unique cross-border franchise. The price-to-sales ratio of 3.35 is also elevated relative to peers, but the net margin of 28.58% supports a higher multiple. The premium valuation relative to book value reflects the market's recognition of EWBC's differentiated business model and consistent profitability. Historically, EWBC's PE ratio has ranged from a low of 5.97 in Q2 2023 to a high of 12.86 in Q4 2021, with the current 11.73 near the upper end of that range. The price-to-book ratio has ranged from 1.13 in Q3 2023 to 1.97 in Q1 2022, and the current 1.75 is above the midpoint, indicating that the stock is trading at a premium to its own history. This suggests that the market is pricing in optimistic expectations for continued profitability and growth, leaving limited room for disappointment. If the bank fails to deliver on these expectations, the stock could face multiple compression.
PE
11.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 6x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.3x
Enterprise Value Multiple
Investment Risk Disclosure
EWBC's financial risks are moderate but not negligible. The interest coverage ratio of 1.19 is thin, meaning a rise in funding costs or a deterioration in asset yields could quickly pressure net interest income, which is the core revenue driver. The cash flow to debt ratio of 0.117 indicates that debt service consumes a meaningful share of operating cash flow, and while the debt-to-equity ratio of 0.357 is conservative, the bank's current ratio of 0.324 reflects the inherent asset-liability mismatch of financial institutions. Revenue concentration in Commercial Banking ($315.6 million of $1.159 billion in Q1 2026) ties performance to business lending and cross-border trade, making a U.S.-Asia trade slowdown a direct earnings risk. Additionally, the sequential revenue decline from $1.255 billion in Q3 2025 to $1.159 billion in Q1 2026 shows that top-line momentum is fragile, and any further compression could pressure the 30.86% net margin.
Market and competitive risks are significant given EWBC's premium valuation. The price-to-book ratio of 1.75 is above the industry average of 1.2x–1.5x and above the midpoint of its own historical range, meaning the market is pricing in continued superior profitability. If the bank fails to deliver, multiple compression could be severe; a reversion to the historical average PB of roughly 1.5x would imply a price near $109, about 14% below current levels. The beta of 0.925 means EWBC is slightly less volatile than the market, but it is still exposed to sector rotation and macro shocks, as evidenced by the 1-month underperformance of 1.71 percentage points versus the S&P 500. Regional banks remain under regulatory scrutiny for commercial real estate exposure and capital requirements, and any new capital rules could constrain growth or force dividend adjustments. Competitive pressure from larger national banks and fintech lenders could also erode EWBC's niche cross-border advantage over time.
The worst-case scenario for EWBC would be a combination of a U.S. recession, a sharp deterioration in commercial credit quality, and a contraction in net interest margin as deposit costs rise while loan yields fall. In this scenario, earnings could decline by 20–30%, and the stock could retest its 52-week low of $92.67, representing a 27% decline from the current price of $126.92. The analyst low target of $134.00 is above the current price, so it does not capture a true bear case; a more realistic downside target would be the 52-week low of $92.67 or the historical PE low of 5.97 applied to a reduced EPS estimate. The max drawdown of -15.71% over the past period shows that the stock can experience moderate peak-to-trough declines, but a sector-wide crisis could produce a larger drawdown. Investors should be prepared for a potential 25–30% loss from current levels in a severe adverse scenario.
FAQ
The key risks ranked by severity are: first, credit risk from commercial real estate exposure, which could force provision increases and erode the 30.86% net margin; second, net interest margin compression if deposit costs rise faster than loan yields, as hinted by the sequential revenue decline from $1.255 billion in Q3 2025 to $1.159 billion in Q1 2026; third, valuation compression risk, since the price-to-book of 1.75 is above historical norms and a reversion to 1.5x would imply a 14% decline; and fourth, macro sensitivity, with a beta of 0.925 exposing the stock to sector-wide selloffs. Regulatory capital requirements are an additional overhang for all regional banks.
The 12-month forecast is based on three scenarios: a base case (50% probability) with a target range of $134.00–$149.75, assuming revenue grows 3–5% and net margin holds near 30%; a bull case (30% probability) targeting $149.75–$160.00, driven by revenue re-acceleration and multiple expansion; and a bear case (20% probability) targeting $92.67–$110.00, triggered by a recession or credit deterioration. The most likely scenario is the base case, with the key assumption that Q2 2026 revenue rebounds above $1.17 billion and net interest margin stabilizes. The analyst average target of $149.75 aligns with the upper end of the base case.
EWBC appears fairly valued to slightly undervalued on earnings but premium on book value. The trailing PE of 11.73 and forward PE of 11.14 are in line with or below the regional bank sector average of 10x–14x, and the PEG ratio of 0.83 is below 1.0, indicating undervaluation relative to growth. However, the price-to-book ratio of 1.75 is above the industry average of 1.2x–1.5x and above the midpoint of EWBC's historical range of 1.13–1.97. This premium is justified by the bank's superior ROE of 14.89% and unique cross-border franchise. The market is pricing in continued profitability and modest growth, leaving limited room for disappointment.
From a risk/reward perspective, EWBC is a good buy for value-oriented investors with a medium risk tolerance. The stock trades at a forward PE of 11.14 and a PEG of 0.83, suggesting it is undervalued relative to expected earnings growth, while the analyst consensus target of $149.75 implies 18.0% upside. The dividend yield of 2.15% and low payout ratio of 25.21% provide income and safety. However, the biggest downside risk is a continued sequential revenue decline, which could push the stock toward its 52-week low of $92.67, a 27% drop. Therefore, it is a good buy for investors who can tolerate short-term volatility and hold for 12–18 months, but less suitable for those seeking quick gains.
EWBC is more suitable for long-term investment than short-term trading. The bank is in a mature growth stage with modest revenue growth of 3.98% year-over-year, a beta of 0.925 indicating lower volatility than the market, and a dividend yield of 2.15% that rewards patient holders. Earnings visibility is moderate, with 16 analysts covering the stock and a consensus Buy rating, but quarterly revenue has been volatile. Short-term traders may find opportunities around earnings releases, but the lack of strong momentum (1-month change of -2.67%) makes quick profits challenging. A suggested minimum holding period is 12–18 months to allow for net interest margin stabilization and valuation re-rating toward the analyst target.
